Cargando…
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum
Autores principales: | Zhou, Jingfeng, Jin, Bei, Jin, Yanli, Liu, Yizhi, Pan, Jingxuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330861/ https://www.ncbi.nlm.nih.gov/pubmed/32641999 http://dx.doi.org/10.7150/thno.47923 |
Ejemplares similares
-
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo
por: Zhou, Jingfeng, et al.
Publicado: (2017) -
Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018) -
Antihelminthic niclosamide modulates dendritic cells activation and function
por: Wu, Chieh-Shan, et al.
Publicado: (2014) -
Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in ovarian cancer
por: Lin, Chi-Kang, et al.
Publicado: (2016) -
Potent Inhibition of Macropinocytosis by Niclosamide in Cancer Cells: A Novel Mechanism for the Anticancer Efficacy for the Antihelminthic
por: Sennoune, Souad R., et al.
Publicado: (2023)